Retevmo 120 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LK6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,879
Award facts
- Contract value 100% obligated
- $16,879.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a $16,879.41 firm fixed-price delivery order from the Defense Logistics Agency on January 15, 2026, for 60 tablets of RETEVMO 120 mg, with completion scheduled for February 6, 2026. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare systems globally.
RETEVMO (selumetinib) is a targeted cancer therapy used primarily in oncology treatment regimens. This delivery order demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor for federal military healthcare procurement, fulfilling specialized medication requirements across the Defense Logistics Agency's medical supply chain. The company's substantial IDC with DLA enables efficient task order execution for diverse pharmaceutical products ranging from specialty oncology agents to generic medications, vaccines, and related medical commodities required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9LK6?
SPE2DR26F9LK6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LK6 worth?
The government has obligated $16,879 on SPE2DR26F9LK6.
Is contract SPE2DR26F9LK6 an order under another contract?
Yes. SPE2DR26F9LK6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LK6 competed?
The extent of competition for SPE2DR26F9LK6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award